TradingNote
Gurus
Top InvestorsCongress TradesInsider Trades

Top Investors

Warren BuffettCathie WoodLi LuRay DalioBill AckmanView all Top Investors
Archive
Industry
AI & ComputeSoftware & DigitalHealthcare InnovationFinancial InfrastructureEnergy & GridIndustrial AutomationConsumer & CommerceReal Estate & AssetsMaterials & ManufacturingListed Vehicles

AI & Compute

Semiconductors & AcceleratorsCloud & AI PlatformsData Center & NetworkingView all AI & Compute
ResearchApp

AIMDW

Ainos, Inc.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-2.5K
ExitQ3 2025
$2.5k
--
$0.0935
Ken GriffinCitadel Advisors
$-1.5K
TrimQ2 2025
$1.5k
--
$0.0935
Ken GriffinCitadel Advisors
$2.0K
AddQ1 2025
$2k
--
$0.0935

Insider Trades

NameValueActionPriceCurrent Price
CYchiang yao-chungDirector
$4.3k2k shares
BuyJun 3, 2026
$2.13
$0.0935
CYchiang yao-chungDirector
$575250 shares
BuyMay 28, 2026
$2.30
$0.0935
CYchiang yao-chungDirector
$4k2k shares
BuyMay 27, 2026
$2.00
$0.0935
LTlee ting-chuanDirector
$209k110k shares
SellMay 26, 2026
$1.90
$0.0935
TCTsai Chun-JungDirector
$1.7k1.1k shares
SellMay 22, 2026
$1.55
$0.0935
TCTaiwan Carbon Nano Technology Corp10 Percent Owner
$97k41k shares
SellMay 26, 2026
$2.36
$0.0935
Trade AIMDW

About Ainos, Inc.

Ainos, Inc. operates as a healthcare enterprise dedicated to advancing medical technologies. Its core focus involves developing both point-of-care diagnostic solutions and innovative, safe therapeutic options for various health conditions. The company's offerings include a COVID-19 antigen rapid test kit. This is complemented by the Ainos' cloud-based test management App, a holistic platform comprising the rapid test kit, a personal mobile application, and an enterprise-level app. Ainos also provides a COVID-19 nucleic acid test. Further technologies under development or offered include point-of-care testing for volatile organic compounds and Very Low-Dose Oral Interferon Alpha, an oral formulation of IFN-a with broad therapeutic potential. The firm is additionally developing a Synthetic RNA (SRNA) technology platform, with specific work being conducted in Taiwan. Beyond these, Ainos' product line extends to women's health, pneumonia, the Ainos Pen, AI Nose, and a variety of other products. Originally incorporated in 1984, the company was formerly known as Amarillo Biosciences, Inc. and rebranded to Ainos, Inc. in May 2021. Its main operations are based in San Diego, California.

CEO
Chun-Hsien Tsai
IPO Date
Jan 8, 2021

Market Data

OpenThe first traded price for the current trading session.
$0.17
HighThe highest traded price in the current trading session.
$0.17
LowThe lowest traded price in the current trading session.
$0.1233
VolumeTotal shares traded during the current trading session.
2.4K
Avg VolumeAverage number of shares traded per session, as reported by FMP.
4.3K
52W HighThe highest traded price over the past 52 weeks.
$0.17
52W LowThe lowest traded price over the past 52 weeks.
$0.1233

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$7.3M
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$19.3M
Dividend YieldAnnualized dividend yield relative to the current share price.
0.00%

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
-$4.6M
RevenueTotal sales from the latest annual income statement.
$124.2K
Net IncomeProfit after expenses and taxes from the latest annual income statement.
-$14.8M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$417.4K
DebtTotal debt from the latest balance sheet.
$11M

Events

EarningsMar 30

actual -2.0814

Top Market Industries

AI & Compute
  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
Software & Digital
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media
Healthcare
  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals
Financial Infrastructure
  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
Energy & Grid
  • Oil, Gas & Fuels
  • Nuclear & Grid Power
  • Renewables & Storage
  • Utilities
  • Energy Services
Industrial Automation & Defense
  • Aerospace & Defense
  • Robotics & Automation
  • Machinery & Equipment
  • Logistics & Transportation
  • Construction & Infrastructure
Consumer & Commerce
  • Retail & E-commerce
  • Restaurants & Food Service
  • Consumer Brands
  • Autos & Mobility
  • Travel & Leisure
Real Estate & Physical Assets
  • REITs
  • Real Estate Services
  • Housing & Building Products

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Financial Infrastructure

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets

Energy & Grid

  • Oil, Gas & Fuels
  • Nuclear & Grid Power
  • Renewables & Storage
  • Utilities
  • Energy Services

Industrial Automation & Defense

  • Aerospace & Defense
  • Robotics & Automation
  • Machinery & Equipment
  • Logistics & Transportation
  • Construction & Infrastructure

Consumer & Commerce

  • Retail & E-commerce
  • Restaurants & Food Service
  • Consumer Brands
  • Autos & Mobility
  • Travel & Leisure

Real Estate & Physical Assets

  • REITs
  • Real Estate Services
  • Housing & Building Products
Trending Industries
  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid
  • Industrial Automation & Defense
  • Consumer & Commerce
  • Real Estate & Physical Assets
Top Investors
  • Warren Buffett
  • Cathie Wood
  • Li Lu
  • Ray Dalio
  • Bill Ackman
  • Duan Yongping
  • Michael Burry
  • Ken Griffin
Trending Stocks
  • NEE
  • NVDA
  • LLY
  • MSFT
  • AAPL
  • META
  • AMD
  • AMZN
Browse
  • App
  • Archive
  • Industries
  • Categories
  • Investors
  • Methodology
  • Watchlist

Trending Industries

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid
  • Industrial Automation & Defense
  • Consumer & Commerce
  • Real Estate & Physical Assets

Top Investors

  • Warren Buffett
  • Cathie Wood
  • Li Lu
  • Ray Dalio
  • Bill Ackman
  • Duan Yongping
  • Michael Burry
  • Ken Griffin

Trending Stocks

  • NEE
  • NVDA
  • LLY
  • MSFT
  • AAPL
  • META
  • AMD
  • AMZN

Browse

  • App
  • Archive
  • Industries
  • Categories
  • Investors
  • Methodology
  • Watchlist
© 2026 TradingNote
AppArchiveIndustriesCategoriesInvestorsMethodologyWatchlistPrivacyTerms